Background and Purpose—Determining the underlying cause of stroke is important to
optimize secondary prevention treatment. Increased blood levels of natriuretic peptides (B …

Context: Various processes including inflammation and endothelial dysfunction have been
implicated in the pathogenesis of cardioembolic (CE) strokes. Objective: To review the …

Background The diagnosis of cerebral thrombosis origin is challenging and remains
unclear. This study aims to identify thrombosis due to cardioembolism (CE) and large artery …

Background: B-type natriuretic peptides (BNPs) have shown promise in detecting
cardioembolic stroke. However, there has been little investigation comparing the diagnostic …

Background We performed a systematic review and meta-analysis to evaluate the value of B-
type natriuretic peptide (BNP) in differentiating cardioembolic (CE) stroke from other …

Background Previous studies reported that the plasma d-dimer level reflects the activity of
thrombus formation in the left atrium of patients with acute cerebral infarction and acute …

Each year, over 5 million people die worldwide from stroke, and at least every sixth patient
who survives will experience another stroke within five years [1]. We are therefore eager to …

Aim The aim of the study is to validate of the use of plasma B-type natriuretic peptide (BNP)
point-of-care test platform in preliminary recognition of cardioembolic stroke patients in the …

Objective: The aim of the study is to validate whether the Recognition Of Stroke In the
Emergency Room (ROSIER) scale can be used by general practitioners (GPs) in an …

Annals of Indian Academy of Neurology, April-June 2014, Vol 17, Issue 2 significantly higher
than that in other the trial of ORG 10172 in acute stroke treatment criteria (TOAST) subtypes …